Bay Colony Advisors’s Health Care Select Sector SPDR Fund XLV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $980K | Sell |
7,271
-1,385
| -16% | -$187K | 0.14% | 147 |
|
2025
Q1 | $1.25M | Buy |
8,656
+651
| +8% | +$94.1K | 0.19% | 111 |
|
2024
Q4 | $1.1M | Sell |
8,005
-636
| -7% | -$87.5K | 0.16% | 129 |
|
2024
Q3 | $1.33M | Sell |
8,641
-576
| -6% | -$88.7K | 0.2% | 113 |
|
2024
Q2 | $1.34M | Sell |
9,217
-283
| -3% | -$41.2K | 0.22% | 93 |
|
2024
Q1 | $1.4M | Buy |
9,500
+166
| +2% | +$24.5K | 0.25% | 86 |
|
2023
Q4 | $1.27M | Buy |
9,334
+3,459
| +59% | +$472K | 0.25% | 89 |
|
2023
Q3 | $756K | Sell |
5,875
-85
| -1% | -$10.9K | 0.18% | 124 |
|
2023
Q2 | $791K | Sell |
5,960
-428
| -7% | -$56.8K | 0.19% | 116 |
|
2023
Q1 | $818K | Buy |
6,388
+385
| +6% | +$49.3K | 0.22% | 110 |
|
2022
Q4 | $815K | Buy |
6,003
+1,030
| +21% | +$140K | 0.22% | 115 |
|
2022
Q3 | $602K | Buy |
4,973
+414
| +9% | +$50.1K | 0.18% | 130 |
|
2022
Q2 | $604K | Sell |
4,559
-3,643
| -44% | -$483K | 0.15% | 145 |
|
2022
Q1 | $1.12M | Buy |
8,202
+5,086
| +163% | +$697K | 0.27% | 98 |
|
2021
Q4 | $439K | Buy |
3,116
+901
| +41% | +$127K | 0.13% | 202 |
|
2021
Q3 | $282K | Buy |
2,215
+148
| +7% | +$18.8K | 0.09% | 269 |
|
2021
Q2 | $260K | Buy |
2,067
+22
| +1% | +$2.77K | 0.09% | 285 |
|
2021
Q1 | $239K | Buy |
2,045
+18
| +0.9% | +$2.1K | 0.09% | 275 |
|
2020
Q4 | $230K | Buy |
+2,027
| New | +$230K | 0.12% | 248 |
|
2020
Q1 | – | Sell |
-1,912
| Closed | -$200K | – | 257 |
|
2019
Q4 | $200K | Buy |
+1,912
| New | +$200K | 0.13% | 246 |
|
2019
Q3 | – | Sell |
-2,760
| Closed | -$256K | – | 271 |
|
2019
Q2 | $256K | Buy |
2,760
+18
| +0.7% | +$1.67K | 0.16% | 171 |
|
2019
Q1 | $249K | Buy |
2,742
+54
| +2% | +$4.9K | 0.16% | 168 |
|
2018
Q4 | $233K | Sell |
2,688
-501
| -16% | -$43.4K | 0.2% | 132 |
|
2018
Q3 | $303K | Sell |
3,189
-43
| -1% | -$4.09K | 0.23% | 127 |
|
2018
Q2 | $270K | Buy |
+3,232
| New | +$270K | 0.19% | 115 |
|